首页> 外文OA文献 >Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

【2h】

Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

机译：用Capecitabine医学或组合化疗治疗转移性乳腺癌（MBC）的临床疗效观察

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
杰李;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 2130 POSTER Updated analysis of an international phase II study evaluating an all-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer (MBC) [J] . N.Tubiana-Mathieu, P.Bougnoux, D.Becquart, European Journal of Cancer Supplements . 2007,第4期

机译：2130海报更新了一项国际II期研究的分析，该研究评估了口服长春瑞滨和卡培他滨的全口服组合作为一线化疗治疗HER2阴性转移性乳腺癌（MBC）
2. Phase II study with dose finding of Oral Vinorelbine in combination with Capecitabine as first-line chemotherapy of Metastatic Breast Cancer (MBC): Preliminary results of the phase II part of the study [J] . F.Nolè, Catania, G.Sanna, European Journal of Cancer Supplements . 2006,第2期

机译：II期研究，口服长春瑞滨联合卡培他滨的剂量确定为转移性乳腺癌（MBC）的一线化疗：II期研究的初步结果
3. 5081 Triple combination of 3-weekly trastuzumab (T) plus oral vinorelbine (VNR) and capecitabine (CAP) as first-line treatment in HER2-positive metastatic breast cancer (MBC): an active and well-tolerated regimen that allows patient compliance [J] . R.Palumbo, A.Bernardo, M.R.Strada, European Journal of Cancer Supplements . 2009,第2期

机译：5081每周3次曲妥珠单抗（T）加上口服长春瑞滨（VNR）和卡培他滨（CAP）的三联组合作为HER2阳性转移性乳腺癌（MBC）的一线治疗：一种有效且耐受性良好的方案，可允许患者依从性
4. Locoregional hyperthermia in combination with chemotherapy for metastatic breast cancer patients: The Mammatherm- trial [C] . J.K. Jueckstock, B. Eberhardt, H.L. Sommer World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：局部热疗联合化疗治疗转移性乳腺癌患者：Mammatherm-试验
5. Investigating age varying effect of access to cancer care on immediate choice of chemotherapy among elderly women with metastatic breast cancer. [D] . Wan, Shaowei. 2010

机译：调查在转移性乳腺癌的老年妇女中，癌症治疗对立即选择化疗的年龄差异影响。
6. Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative metastatic breast cancer [O] . Xue-Lian Chen, Feng Du, Ruo-Xi Hong, 2016

机译：对于激素受体阳性和HER2阴性转移性乳腺癌的患者在一线基于卡培他滨的联合化疗后激素治疗可能是比卡培他滨更好的维持治疗方法
7. Hormonal therapy might be a better choice as maintenance treatment than capecitabine after response to first-line capecitabine-based combination chemotherapy for patients with hormone receptor-positive and HER2-negative, metastatic breast cancer [O] . Xue-Lian Chen, Feng Du, Ruo-Xi Hong, 2016

机译：对于激素受体阳性和HER2阴性，转移性乳腺癌的患者，在一线基于卡培他滨的联合化疗后，激素治疗可能是比卡培他滨更好的维持治疗方法

Clinical Curative Effect Observation of the Treatment of Metastatic Breast Cancer (MBC) with Capecitabine Medicine or Combination Chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅